NATCO opens semaglutide market at ₹1,290, sets early price benchmark
NATCO’s Day 1 launch on patent expiry lowers semaglutide prices as more players prepare to enter
NATCO’s Day 1 launch on patent expiry lowers semaglutide prices as more players prepare to enter
What's Your Reaction?
DDP Editor
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
